[Featured Stock] Moon Orders Review of Russian Vaccine... IDIS Hits Upper Limit
[Asia Economy Reporter Ji Yeon-jin] Related stocks are soaring on the 22nd as President Moon Jae-in has ordered a review of the possibility of introducing Russia's COVID-19 vaccine, Sputnik V.
Idis started rising immediately after the market opened and reached the price limit (29.96%) during the session, closing at 590 won. Its affiliate, Etron, is trading at 1,040 won, up 25.91%.
These two stocks are considered related stocks as they invested in Korea Corus, which has been contract manufacturing (CMO) Russia's Sputnik V domestically since December last year.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Earlier, President Moon reportedly instructed to review the possibility of introducing the Sputnik V vaccine. The Sputnik V vaccine was developed and approved by Russia in August last year, making it the world's first.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.